Request for Covid-19 Impact Assessment of this Report
The United States NK Cells market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global NK Cells market, reaching US$ million by the year 2028. As for the Europe NK Cells landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main NK Cells players cover Chipscreen Biosciences, Affimed NV, Altor BioScience, and Innate Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of NK Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Mogamulizumab
Lorvotuzumab Mertansine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cancer
Cardiovascular Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NK Cells Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for NK Cells by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for NK Cells by Country/Region, 2017, 2022 & 2028
2.2 NK Cells Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 NK Cells Sales by Type
2.3.1 Global NK Cells Sales Market Share by Type (2017-2022)
2.3.2 Global NK Cells Revenue and Market Share by Type (2017-2022)
2.3.3 Global NK Cells Sale Price by Type (2017-2022)
2.4 NK Cells Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 NK Cells Sales by Application
2.5.1 Global NK Cells Sale Market Share by Application (2017-2022)
2.5.2 Global NK Cells Revenue and Market Share by Application (2017-2022)
2.5.3 Global NK Cells Sale Price by Application (2017-2022)
3 Global NK Cells by Company
3.1 Global NK Cells Breakdown Data by Company
3.1.1 Global NK Cells Annual Sales by Company (2020-2022)
3.1.2 Global NK Cells Sales Market Share by Company (2020-2022)
3.2 Global NK Cells Annual Revenue by Company (2020-2022)
3.2.1 Global NK Cells Revenue by Company (2020-2022)
3.2.2 Global NK Cells Revenue Market Share by Company (2020-2022)
3.3 Global NK Cells Sale Price by Company
3.4 Key Manufacturers NK Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NK Cells Product Location Distribution
3.4.2 Players NK Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NK Cells by Geographic Region
4.1 World Historic NK Cells Market Size by Geographic Region (2017-2022)
4.1.1 Global NK Cells Annual Sales by Geographic Region (2017-2022)
4.1.2 Global NK Cells Annual Revenue by Geographic Region
4.2 World Historic NK Cells Market Size by Country/Region (2017-2022)
4.2.1 Global NK Cells Annual Sales by Country/Region (2017-2022)
4.2.2 Global NK Cells Annual Revenue by Country/Region
4.3 Americas NK Cells Sales Growth
4.4 APAC NK Cells Sales Growth
4.5 Europe NK Cells Sales Growth
4.6 Middle East & Africa NK Cells Sales Growth
5 Americas
5.1 Americas NK Cells Sales by Country
5.1.1 Americas NK Cells Sales by Country (2017-2022)
5.1.2 Americas NK Cells Revenue by Country (2017-2022)
5.2 Americas NK Cells Sales by Type
5.3 Americas NK Cells Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cells Sales by Region
6.1.1 APAC NK Cells Sales by Region (2017-2022)
6.1.2 APAC NK Cells Revenue by Region (2017-2022)
6.2 APAC NK Cells Sales by Type
6.3 APAC NK Cells Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NK Cells by Country
7.1.1 Europe NK Cells Sales by Country (2017-2022)
7.1.2 Europe NK Cells Revenue by Country (2017-2022)
7.2 Europe NK Cells Sales by Type
7.3 Europe NK Cells Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NK Cells by Country
8.1.1 Middle East & Africa NK Cells Sales by Country (2017-2022)
8.1.2 Middle East & Africa NK Cells Revenue by Country (2017-2022)
8.2 Middle East & Africa NK Cells Sales by Type
8.3 Middle East & Africa NK Cells Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NK Cells
10.3 Manufacturing Process Analysis of NK Cells
10.4 Industry Chain Structure of NK Cells
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NK Cells Distributors
11.3 NK Cells Customer
12 World Forecast Review for NK Cells by Geographic Region
12.1 Global NK Cells Market Size Forecast by Region
12.1.1 Global NK Cells Forecast by Region (2023-2028)
12.1.2 Global NK Cells Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global NK Cells Forecast by Type
12.7 Global NK Cells Forecast by Application
13 Key Players Analysis
13.1 Chipscreen Biosciences
13.1.1 Chipscreen Biosciences Company Information
13.1.2 Chipscreen Biosciences NK Cells Product Offered
13.1.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chipscreen Biosciences Main Business Overview
13.1.5 Chipscreen Biosciences Latest Developments
13.2 Affimed NV
13.2.1 Affimed NV Company Information
13.2.2 Affimed NV NK Cells Product Offered
13.2.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Affimed NV Main Business Overview
13.2.5 Affimed NV Latest Developments
13.3 Altor BioScience
13.3.1 Altor BioScience Company Information
13.3.2 Altor BioScience NK Cells Product Offered
13.3.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Altor BioScience Main Business Overview
13.3.5 Altor BioScience Latest Developments
13.4 Innate Pharma
13.4.1 Innate Pharma Company Information
13.4.2 Innate Pharma NK Cells Product Offered
13.4.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Innate Pharma Main Business Overview
13.4.5 Innate Pharma Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda NK Cells Product Offered
13.5.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Sorrento Therapeutics
13.6.1 Sorrento Therapeutics Company Information
13.6.2 Sorrento Therapeutics NK Cells Product Offered
13.6.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sorrento Therapeutics Main Business Overview
13.6.5 Sorrento Therapeutics Latest Developments
13.7 NantKwest
13.7.1 NantKwest Company Information
13.7.2 NantKwest NK Cells Product Offered
13.7.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 NantKwest Main Business Overview
13.7.5 NantKwest Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb NK Cells Product Offered
13.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 NKT
13.9.1 NKT Company Information
13.9.2 NKT NK Cells Product Offered
13.9.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 NKT Main Business Overview
13.9.5 NKT Latest Developments
13.10 Henry Ford Health Services
13.10.1 Henry Ford Health Services Company Information
13.10.2 Henry Ford Health Services NK Cells Product Offered
13.10.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Henry Ford Health Services Main Business Overview
13.10.5 Henry Ford Health Services Latest Developments
13.11 Fortress Biotech
13.11.1 Fortress Biotech Company Information
13.11.2 Fortress Biotech NK Cells Product Offered
13.11.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fortress Biotech Main Business Overview
13.11.5 Fortress Biotech Latest Developments
14 Research Findings and Conclusion
Table 1. NK Cells Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. NK Cells Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Mogamulizumab
Table 4. Major Players of Lorvotuzumab Mertansine
Table 5. Major Players of Others
Table 6. Global NK Cells Sales by Type (2017-2022) & (g)
Table 7. Global NK Cells Sales Market Share by Type (2017-2022)
Table 8. Global NK Cells Revenue by Type (2017-2022) & ($ million)
Table 9. Global NK Cells Revenue Market Share by Type (2017-2022)
Table 10. Global NK Cells Sale Price by Type (2017-2022) & (USD/g)
Table 11. Global NK Cells Sales by Application (2017-2022) & (g)
Table 12. Global NK Cells Sales Market Share by Application (2017-2022)
Table 13. Global NK Cells Revenue by Application (2017-2022)
Table 14. Global NK Cells Revenue Market Share by Application (2017-2022)
Table 15. Global NK Cells Sale Price by Application (2017-2022) & (USD/g)
Table 16. Global NK Cells Sales by Company (2020-2022) & (g)
Table 17. Global NK Cells Sales Market Share by Company (2020-2022)
Table 18. Global NK Cells Revenue by Company (2020-2022) ($ Millions)
Table 19. Global NK Cells Revenue Market Share by Company (2020-2022)
Table 20. Global NK Cells Sale Price by Company (2020-2022) & (USD/g)
Table 21. Key Manufacturers NK Cells Producing Area Distribution and Sales Area
Table 22. Players NK Cells Products Offered
Table 23. NK Cells Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global NK Cells Sales by Geographic Region (2017-2022) & (g)
Table 27. Global NK Cells Sales Market Share Geographic Region (2017-2022)
Table 28. Global NK Cells Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global NK Cells Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global NK Cells Sales by Country/Region (2017-2022) & (g)
Table 31. Global NK Cells Sales Market Share by Country/Region (2017-2022)
Table 32. Global NK Cells Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global NK Cells Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas NK Cells Sales by Country (2017-2022) & (g)
Table 35. Americas NK Cells Sales Market Share by Country (2017-2022)
Table 36. Americas NK Cells Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas NK Cells Revenue Market Share by Country (2017-2022)
Table 38. Americas NK Cells Sales by Type (2017-2022) & (g)
Table 39. Americas NK Cells Sales Market Share by Type (2017-2022)
Table 40. Americas NK Cells Sales by Application (2017-2022) & (g)
Table 41. Americas NK Cells Sales Market Share by Application (2017-2022)
Table 42. APAC NK Cells Sales by Region (2017-2022) & (g)
Table 43. APAC NK Cells Sales Market Share by Region (2017-2022)
Table 44. APAC NK Cells Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC NK Cells Revenue Market Share by Region (2017-2022)
Table 46. APAC NK Cells Sales by Type (2017-2022) & (g)
Table 47. APAC NK Cells Sales Market Share by Type (2017-2022)
Table 48. APAC NK Cells Sales by Application (2017-2022) & (g)
Table 49. APAC NK Cells Sales Market Share by Application (2017-2022)
Table 50. Europe NK Cells Sales by Country (2017-2022) & (g)
Table 51. Europe NK Cells Sales Market Share by Country (2017-2022)
Table 52. Europe NK Cells Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe NK Cells Revenue Market Share by Country (2017-2022)
Table 54. Europe NK Cells Sales by Type (2017-2022) & (g)
Table 55. Europe NK Cells Sales Market Share by Type (2017-2022)
Table 56. Europe NK Cells Sales by Application (2017-2022) & (g)
Table 57. Europe NK Cells Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa NK Cells Sales by Country (2017-2022) & (g)
Table 59. Middle East & Africa NK Cells Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa NK Cells Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa NK Cells Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa NK Cells Sales by Type (2017-2022) & (g)
Table 63. Middle East & Africa NK Cells Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa NK Cells Sales by Application (2017-2022) & (g)
Table 65. Middle East & Africa NK Cells Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of NK Cells
Table 67. Key Market Challenges & Risks of NK Cells
Table 68. Key Industry Trends of NK Cells
Table 69. NK Cells Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. NK Cells Distributors List
Table 72. NK Cells Customer List
Table 73. Global NK Cells Sales Forecast by Region (2023-2028) & (g)
Table 74. Global NK Cells Sales Market Forecast by Region
Table 75. Global NK Cells Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global NK Cells Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas NK Cells Sales Forecast by Country (2023-2028) & (g)
Table 78. Americas NK Cells Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC NK Cells Sales Forecast by Region (2023-2028) & (g)
Table 80. APAC NK Cells Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe NK Cells Sales Forecast by Country (2023-2028) & (g)
Table 82. Europe NK Cells Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa NK Cells Sales Forecast by Country (2023-2028) & (g)
Table 84. Middle East & Africa NK Cells Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global NK Cells Sales Forecast by Type (2023-2028) & (g)
Table 86. Global NK Cells Sales Market Share Forecast by Type (2023-2028)
Table 87. Global NK Cells Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global NK Cells Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global NK Cells Sales Forecast by Application (2023-2028) & (g)
Table 90. Global NK Cells Sales Market Share Forecast by Application (2023-2028)
Table 91. Global NK Cells Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global NK Cells Revenue Market Share Forecast by Application (2023-2028)
Table 93. Chipscreen Biosciences Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 94. Chipscreen Biosciences NK Cells Product Offered
Table 95. Chipscreen Biosciences NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 96. Chipscreen Biosciences Main Business
Table 97. Chipscreen Biosciences Latest Developments
Table 98. Affimed NV Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 99. Affimed NV NK Cells Product Offered
Table 100. Affimed NV NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 101. Affimed NV Main Business
Table 102. Affimed NV Latest Developments
Table 103. Altor BioScience Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 104. Altor BioScience NK Cells Product Offered
Table 105. Altor BioScience NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 106. Altor BioScience Main Business
Table 107. Altor BioScience Latest Developments
Table 108. Innate Pharma Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 109. Innate Pharma NK Cells Product Offered
Table 110. Innate Pharma NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 111. Innate Pharma Main Business
Table 112. Innate Pharma Latest Developments
Table 113. Takeda Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 114. Takeda NK Cells Product Offered
Table 115. Takeda NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 116. Takeda Main Business
Table 117. Takeda Latest Developments
Table 118. Sorrento Therapeutics Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 119. Sorrento Therapeutics NK Cells Product Offered
Table 120. Sorrento Therapeutics NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 121. Sorrento Therapeutics Main Business
Table 122. Sorrento Therapeutics Latest Developments
Table 123. NantKwest Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 124. NantKwest NK Cells Product Offered
Table 125. NantKwest NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 126. NantKwest Main Business
Table 127. NantKwest Latest Developments
Table 128. Bristol-Myers Squibb Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol-Myers Squibb NK Cells Product Offered
Table 130. Bristol-Myers Squibb NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 131. Bristol-Myers Squibb Main Business
Table 132. Bristol-Myers Squibb Latest Developments
Table 133. NKT Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 134. NKT NK Cells Product Offered
Table 135. NKT NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 136. NKT Main Business
Table 137. NKT Latest Developments
Table 138. Henry Ford Health Services Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 139. Henry Ford Health Services NK Cells Product Offered
Table 140. Henry Ford Health Services NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 141. Henry Ford Health Services Main Business
Table 142. Henry Ford Health Services Latest Developments
Table 143. Fortress Biotech Basic Information, NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 144. Fortress Biotech NK Cells Product Offered
Table 145. Fortress Biotech NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 146. Fortress Biotech Main Business
Table 147. Fortress Biotech Latest Developments
List of Figures
Figure 1. Picture of NK Cells
Figure 2. NK Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NK Cells Sales Growth Rate 2017-2028 (g)
Figure 7. Global NK Cells Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. NK Cells Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Mogamulizumab
Figure 10. Product Picture of Lorvotuzumab Mertansine
Figure 11. Product Picture of Others
Figure 12. Global NK Cells Sales Market Share by Type in 2021
Figure 13. Global NK Cells Revenue Market Share by Type (2017-2022)
Figure 14. NK Cells Consumed in Cancer
Figure 15. Global NK Cells Market: Cancer (2017-2022) & (g)
Figure 16. NK Cells Consumed in Cardiovascular Diseases
Figure 17. Global NK Cells Market: Cardiovascular Diseases (2017-2022) & (g)
Figure 18. NK Cells Consumed in Others
Figure 19. Global NK Cells Market: Others (2017-2022) & (g)
Figure 20. Global NK Cells Sales Market Share by Application (2017-2022)
Figure 21. Global NK Cells Revenue Market Share by Application in 2021
Figure 22. NK Cells Revenue Market by Company in 2021 ($ Million)
Figure 23. Global NK Cells Revenue Market Share by Company in 2021
Figure 24. Global NK Cells Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global NK Cells Revenue Market Share by Geographic Region in 2021
Figure 26. Global NK Cells Sales Market Share by Region (2017-2022)
Figure 27. Global NK Cells Revenue Market Share by Country/Region in 2021
Figure 28. Americas NK Cells Sales 2017-2022 (g)
Figure 29. Americas NK Cells Revenue 2017-2022 ($ Millions)
Figure 30. APAC NK Cells Sales 2017-2022 (g)
Figure 31. APAC NK Cells Revenue 2017-2022 ($ Millions)
Figure 32. Europe NK Cells Sales 2017-2022 (g)
Figure 33. Europe NK Cells Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa NK Cells Sales 2017-2022 (g)
Figure 35. Middle East & Africa NK Cells Revenue 2017-2022 ($ Millions)
Figure 36. Americas NK Cells Sales Market Share by Country in 2021
Figure 37. Americas NK Cells Revenue Market Share by Country in 2021
Figure 38. United States NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC NK Cells Sales Market Share by Region in 2021
Figure 43. APAC NK Cells Revenue Market Share by Regions in 2021
Figure 44. China NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 48. India NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe NK Cells Sales Market Share by Country in 2021
Figure 51. Europe NK Cells Revenue Market Share by Country in 2021
Figure 52. Germany NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 53. France NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa NK Cells Sales Market Share by Country in 2021
Figure 58. Middle East & Africa NK Cells Revenue Market Share by Country in 2021
Figure 59. Egypt NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country NK Cells Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of NK Cells in 2021
Figure 65. Manufacturing Process Analysis of NK Cells
Figure 66. Industry Chain Structure of NK Cells
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...